A groundbreaking HIV prevention shot, Yeztugo, has been approved by the FDA, offering hope for at-risk individuals with its twice-yearly injections. However, concerns about cost and accessibility remain.
The FDA has approved Gilead's Yeztugo, a twice-yearly injection that could revolutionize HIV prevention, boasting a 99.9% effectiveness. While hailed as a breakthrough, concerns over pricing remain, with activists urging for affordability.
A shocking number of men struggle with delayed orgasm, taking over 30 minutes to climax. This article explores the causes, implications, and potential treatments for this lesser-known issue affecting many.
A new study suggests bacterial vaginosis (BV) should be classified as a sexually transmitted infection, revealing that treating both partners significantly reduces recurrence rates. Learn how this could change treatment protocols and improve women's health.
